Joshua Omale: Why Cancer Control Keeps Arriving Too Late?
Joshua Omale/LinkedIn

Joshua Omale: Why Cancer Control Keeps Arriving Too Late?

Joshua Omale, Pediatric Oncology Advocate, Innovation Council Member at Coalition Against Childhood Cancer (CAC2), shared a post on LinkedIn:

Prevention is not weak in cancer control. It is weak in cancer policy.

Most cancers in low-resource settings are discovered late not always because people delay, but because systems are largely built for treatment, not prevention.

  • Budgets often favor hospitals over communities.
  • Guidelines exist without delivery mechanisms.
  • Screening is centralized instead of embedded.
  • Vaccines are available without demand creation.
  • So “prevention” becomes a slogan, not an operating system.

The result?

We invest heavily at the point of disease and lightly at the point of risk. True cancer prevention is not just: vaccines, screening and education.

It is:

  • financing models that reward early action.
  • primary care that can recognize risk.
  • trust between communities and health systems.
  • data that reaches decision-makers before crises.

Until prevention is designed as infrastructure, not an add-on, cancer control will always arrive too late.”

Joshua Omale

More posts featuring Joshua Omale on OncoDaily.